Pricing pressures in US market now aggravated by fallout of drug price rise probe
Sun Pharma, Dr Reddy's, Jubilant Life, Strides Shasun, Aurobindo Pharma were down 5% each over possible US probe into cartelisation
Suspense over US election result also weighs on market as stocks fall 3-7 percent
Sun Pharmaceutical Industries on Thursday said it has launched generic versions of Daiichi Sankyo medicines
Sun will also pay more contingent on meeting drug development and sales milestones as well as tiered royalty on sales of Seciera for the company
The comapny's stock was trading at Rs 742, down 0.66 per cent from its previous close, on BSE
This is the second tie-up between the International Centre for Genetic Engineering and Biotechnology and Sun Pharmaceuticals
Sun Pharma will fund and support further development of the vaccine
This is a class III recall initiated voluntarily by Sun
The tablets have been manufactured by Sun Pharma at its Halol plant
The medical reps contend Sun management has been "arbitrarily" transferring them after taking control
After tying up with Nykaa, pharma major plans to sell products online
Firm says treasury team has done a commendable job
Here is an opportunity to get a 13% return in less than a month; the trouble is that the buyback ratio isn't exciting
The strike is also against company's decision to have a uniform structure for paid leave for employees
Mitsubishi Tanabe Pharma Corporation will market and distribute all the 14 brands
Sun Pharma forayed into Japanese prescription market by acquiring 14 brands from Novartis for $293 million
The company has been pulled up by USFDA for using contaminated raw materials
Overall consolidated revenue grew 23% to Rs 8,007 cr
Approvals for US launches and clearance of Halol plant key for Sun Pharma's earning upgrades